SPY756.88−0.39%QQQ686.38−0.58%BTC/USD71,500.00−3.28%DIA524.22−0.04%GLD356.92−2.26%TLT80.62−0.37%

Hinge Health Inc

HNGENYSE

Trade with Public

$120.97

-0.75-0.62%

Last update: Nov 12, 9:38 AM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Hinge Health (HNGE) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Hinge Health (HNGE) stock.

Analyst Consensus — 18 Analysts

2S.Buy

15Buy

1Hold

# Analysts18

Latest Upgrades and Downgrades for Hinge Health Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Freedom Capital Markets	Gene Mannheimer	PT Raise	Buy	$103→$135
—	Morgan Stanley	Craig Hettenbach	PT Raise	Overweight	$117→$131
—	Truist Securities	Jailendra Singh	PT Raise	Buy	$112→$145
—	Wells Fargo	Stan Berenshteyn	PT Raise	Overweight	$103→$132
—	RBC Capital	Rishi Jaluria	PT Raise	Outperform	$110→$135
—	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$125→$150
—	Canaccord Genuity	Richard Close	PT Raise	Buy	$105→$134
—	Stifel	David Grossman	PT Raise	Buy	$130→$135
—	Needham	Ryan MacDonald	PT Raise	Buy	$115→$135
—	Stifel	David Grossman	PT Raise	Buy	$115→$130
—	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$125→$140
—	Barclays	Saket Kalia	PT Raise	Overweight	$100→$110
—	Needham	Ryan MacDonald	PT Raise	Buy	$97→$115
—	Baird	Vikram Kesavabhotla	PT Raise	Neutral	$85→$90
—	Stifel	David Grossman	PT Raise	Buy	$96→$115
—	Truist Securities	Jailendra Singh	PT Raise	Buy	$85→$112
—	RBC Capital	Rishi Jaluria	PT Raise	Outperform	$75→$110
—	Citizens	Aaron Kimson	PT Raise	Market Outperform	$96→$107
—	Wells Fargo	Stan Berenshteyn	PT Raise	Overweight	$90→$103
—	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$100→$105

Hinge Health Inc

Hinge Health (HNGE) Stock Price Target 2026

Latest Upgrades and Downgrades for Hinge Health Stock

Hinge Health (HNGE) Stock Price Target 2026

Latest Upgrades and Downgrades for Hinge Health Stock

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PRO
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PRO
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

Hinge Health Inc

Hinge Health (HNGE) Stock Price Target 2026

Latest Upgrades and Downgrades for Hinge Health Stock

Hinge Health (HNGE) Stock Price Target 2026

Latest Upgrades and Downgrades for Hinge Health Stock

Analyst Ratings News

PROFreedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PROMorgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PROTruist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PROWells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRORBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PROEvercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

People Also Watch

People Also Watch

Analyst Ratings News

PROFreedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PROMorgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PROTruist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PROWells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRORBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PROEvercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

PRO
Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PRO
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150

PRO
Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135

PRO
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131

PRO
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145

PRO
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132

PRO
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

PRO
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150